ISD - CDS Agonist

Naked or Complexed with Lyovec™

SPECIFICATIONS

Specifications

Target

Cytosolic DNA sensors (CDSs)

Sequence

5’-TACAGATCTACTAGTGATCTATGACTGATCTGTACATGATCTACA-3’

3’-ATGTCTAGATGATCACTAGATACTGACTAGACATGTACTAGATGT-5’

Working concentration
  • 100 ng - 10 μg/ml transfected ISD naked
  • 300 ng - 10 μg/ml ISD/LyoVec™
Formulation buffer

Naked

Reconstitution buffer
Sterile endotoxin-free water (provided)
Endotoxin

Negative (tested using EndotoxDetect™ assay)

Tested applications

Cellular assays

Quality control

 Each lot is functionally tested and validated using THP1-Blue™ ISG Cells.

Additional information

Control: ISD Control single-stranded oligonucleotide

CONTENTS

Contents

  • Product: 
    ISD Naked
  • Cat code: 
    tlrl-isdn
  • Quantity: 
    200 µg
Includes:

1.5 ml of sterile endotoxin-free water

Shipping & Storage

  • Shipping method:  Room temperature
  • Storage:

    • Upon receipt, store at -20°C.
    Stability: The reconstituted product is stable up to 6 months at -20 °C.

    Caution:

    • Avoid repeated freeze-thaw cycles

Details

STING (stimulator of interferon genes) has become a focal point in immunology research and drug discovery [1, 2]. In a healthy individual, STING functions as a signaling hub, orchestrating immune responses to pathogenic, tumoral, or self-DNA detected in the cytoplasm [2]. Upon activation, STING induces type I interferon (IFN) production through TANK-binding-kinase-I (TBK1)-mediated IFN regulatory factor (IRF3) signaling [2]. STING activation also leads to NF‑κB-dependent inflammatory cytokine production [2]. In some autoimmune diseases such as STING-associated vasculopathy with onset in infancy (SAVI), STING is constitutively activated resulting in high IFN production [3, 4]. The discovery of a mechanism to pharmacologically inhibit STING should lead to new treatments for such diseases.

 

Reference:

1. Haag S.M. et al., 2018. Targeting STING with covalent small-molecule inhibitors. Nature 559:269-73.
2. Ishikawa H. & Barber G.N. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674-8.
3. Liu Y. et al., 2014. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 371:507-18.
4. Jeremiah N. et al., 2013. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest. 124:5516-20.

DOCUMENTS

Documents

ISD Naked

Technical Data Sheet

Safety Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?